Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain

Dysregulation of ErbB-family signaling underlies numerous pathologies and has been therapeutically targeted through inhibiting ErbB-receptors themselves or their cognate ligands. For the latter, “decoy” antibodies have been developed to sequester ligands including heparin-binding epidermal growth fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Miles A., Moss, Marcia L., Powell, Gary, Petrovich, Robert, Edwards, Lori, Meyer, Aaron S., Griffith, Linda G., Lauffenburger, Douglas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609913/
https://www.ncbi.nlm.nih.gov/pubmed/26477568
http://dx.doi.org/10.1038/srep15150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609913/
https://www.ncbi.nlm.nih.gov/pubmed/26477568
http://dx.doi.org/10.1038/srep15150

Ejemplares similares